QC
RMD icon

Quent Capital’s ResMed RMD Stock Holding History

Quent Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Sell
792
-9
-1% -$2.24K 0.01% 411
2025
Q4 		$193K Buy
801
+6
+0.8% +$1.53K 0.01% 399
2025
Q3 		$218K Sell
795
-11
-1% -$3K 0.02% 268
2025
Q2 		$208K Buy
806
+3
+0.4% +$716 0.02% 270
2025
Q1 		$180K Sell
803
-14
-2% -$3.27K 0.02% 277
2024
Q4 		$187K Sell
817
-1
-0.1% -$241 0.02% 270
2024
Q3 		$198K Sell
818
-5
-0.6% -$1.12K 0.02% 337
2024
Q2 		$157K Buy
823
+66
+9% +$13.4K 0.02% 362
2024
Q1 		$150K Sell
757
-26
-3% -$4.76K 0.02% 391
2023
Q4 		$135K Buy
783
+38
+5% +$5.84K 0.02% 378
2023
Q3 		$110K Buy
745
+57
+8% +$10.3K 0.02% 386
2023
Q2 		$150K Buy
688
+8
+1% +$1.78K 0.02% 337
2023
Q1 		$149K Buy
680
+13
+2% +$2.82K 0.03% 334
2022
Q4 		$139K Buy
667
+35
+6% +$7.69K 0.03% 337
2022
Q3 		$138K Buy
632
+10
+2% +$2.28K 0.03% 309
2022
Q2 		$130K Buy
622
+37
+6% +$7.88K 0.03% 307
2022
Q1 		$142K Sell
585
-28
-5% -$6.77K 0.03% 345
2021
Q4 		$160K Buy
+613
New +$159K 0.03% 318

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quent Capital's RMD Position: Q1 2026 in Review

Quent Capital reduced its ResMed (RMD) stake by 1.1% in Q1 2026, selling an estimated $2.24K and leaving 792 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #411.

Quent Capital first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $218K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Quent Capital held 792 shares of ResMed worth $178K as of Q1 2026.
  • Quent Capital sold 9 ResMed shares in Q1 2026, an estimated $2.24K.
  • ResMed made up 0.01% of Quent Capital's portfolio in Q1 2026, its #411 holding.
  • Quent Capital first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • Quent Capital's ResMed position peaked at $218K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.